{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:17:51Z","timestamp":1773296271141,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Center of Drug-Delivery Systems in Universities of Guangdong Province","award":["GCZX-A0802"],"award-info":[{"award-number":["GCZX-A0802"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ijpharm.2012.02.002","type":"journal-article","created":{"date-parts":[[2012,2,11]],"date-time":"2012-02-11T15:24:35Z","timestamp":1328973875000},"page":"385-392","source":"Crossref","is-referenced-by-count":15,"title":["Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process"],"prefix":"10.1016","volume":"427","author":[{"given":"Yinhe","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiwan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2012.02.002_bib0005","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.fct.2003.08.021","article-title":"The FEMA GRAS assessment of cinnamyl derivatives used as flavor ingredients","volume":"42","author":"Adams","year":"2004","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1378\/chest.120.3_suppl.89S","article-title":"Delivery options and devices for aerosolized therapeutics","volume":"120","author":"Anderson","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2010.11.037","article-title":"Plume temperature emitted from metered dose inhalers","volume":"405","author":"Brambilla","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0378-5173(99)00137-4","article-title":"Modulation of aerosol clouds produced by pressurised inhalation aerosols","volume":"186","author":"Brambilla","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0091-6749(99)70034-5","article-title":"The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability","volume":"104","author":"Brindley","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0030","first-page":"1","article-title":"Towards the rational formulation of metered dose inhalers","volume":"3","author":"Byron","year":"1992","journal-title":"J. Biopharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2008.10.025","article-title":"Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles","volume":"369","author":"Chokshi","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2005.01.003","article-title":"Novel sustained release microspheres for pulmonary drug delivery","volume":"104","author":"Cook","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/10611860108997937","article-title":"Novel nanoparticles for pulmonary drug administration","volume":"9","author":"Dickinson","year":"2001","journal-title":"J. Drug Targ."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0050","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1023\/A:1015888704365","article-title":"Effect of freezing on aggregation of human growth hormone","volume":"8","author":"Eckhardt","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11095-008-9707-z","article-title":"Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers","volume":"26","author":"Engstrom","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0060","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.451537","article-title":"A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin","volume":"204","author":"Goldstein","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/oxfordjournals.jbchem.a123055","article-title":"Freezing denaturation of ovalbumin at acid pH","volume":"107","author":"Koseki","year":"1990","journal-title":"J. Biochem."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0070","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2009.10.032","article-title":"Novel pMDI formulations for pulmonary delivery of proteins","volume":"385","author":"Li","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0075","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11095-010-0201-z","article-title":"Inhalable microparticles as carriers for pulmonary delivery of thymopentin-loaded solid lipid nanoparticles","volume":"27","author":"Li","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0167-7322(99)00196-8","article-title":"Co-surfactant properties of ketones","volume":"84","author":"Meziani","year":"2000","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0167-7322(97)00061-5","article-title":"Can aldehydes participate in the nanostructuration of liquids containing charged micelles?","volume":"73","author":"Meziani","year":"1997","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijpharm.2009.03.031","article-title":"Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers","volume":"375","author":"Nyambura","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2009.01.005","article-title":"The processing of nanoparticles containing protein for suspension in hydrofluoroalkane propellants","volume":"372","author":"Nyambura","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0100","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1007\/s11095-008-9647-7","article-title":"Formation of zinc-peptide spherical microparticles during lyophilization from tert-butyl alcohol\/water co-solvent system","volume":"25","author":"Qian","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0105","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","article-title":"Nanosuspensions in drug delivery","volume":"3","author":"Rabinow","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0169-409X(03)00079-6","article-title":"The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers","volume":"55","author":"Smyth","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0115","first-page":"241","article-title":"A comparative study on the neurotoxicity of n-pentane, n-hexane, and n-heptane in the rat","volume":"37","author":"Takeuchi","year":"1980","journal-title":"Brit. J. Ind. Med."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0120","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3109\/15563658108990348","article-title":"A comparative study of the toxicity of n-pentane, n-hexane, and n-heptane to the peripheral nerve of the rat","volume":"18","author":"Takeuchi","year":"1981","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0125","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1002\/jps.22091","article-title":"Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers","volume":"99","author":"Tam","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2011.03.069","article-title":"A novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants","volume":"413","author":"Tan","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11095-004-9021-3","article-title":"Crystallization of cephalothin sodium during lyophilization from tert-butyl alcohol\u2013water cosolvent system","volume":"22","author":"Telang","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0140","doi-asserted-by":"crossref","first-page":"12001","DOI":"10.1073\/pnas.182233999","article-title":"Trojan particles: large porous carriers of nanoparticles for drug delivery","volume":"99","author":"Tsapis","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0145","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1021\/la9016432","article-title":"Scanning probe microscopy method for nanosuspension stabilizer selection","volume":"25","author":"Verma","year":"2009","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5173(99)00134-9","article-title":"Drug\u2013surfactant\u2013propellant interactions in HFA-formulations","volume":"186","author":"Vervaet","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2009.03.020","article-title":"Characterization of a new inhalable thymopentin formulation","volume":"375","author":"Wang","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0160","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3109\/03639049809082724","article-title":"Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler","volume":"24","author":"Williams","year":"1998","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejps.2007.10.007","article-title":"Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes","volume":"33","author":"Wu","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11095-007-9466-2","article-title":"Core-shell particles for the dispersion of small polar drugs and biomolecules in hydrofluoroalkane propellants","volume":"25","author":"Wu","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0175","doi-asserted-by":"crossref","first-page":"12104","DOI":"10.1021\/la702108x","article-title":"Biocompatible and biodegradable copolymer stabilizers for hydrofluoroalkane dispersions: a colloidal probe microscopy investigation","volume":"23","author":"Wu","year":"2007","journal-title":"Langmuir"},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0180","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.addr.2011.02.001","article-title":"Physical and chemical stability of drug nanoparticles","volume":"63","author":"Wu","year":"2011","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0185","doi-asserted-by":"crossref","first-page":"8096","DOI":"10.1021\/jp071205y","article-title":"Understanding solvation in hydrofluoroalkanes: ab initio calculations and chemical force microscopy","volume":"111","author":"Wu","year":"2007","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijpharm.2012.02.002_bib0190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.addr.2010.11.002","article-title":"Formation, characterization, and fate of inhaled drug nanoparticles","volume":"63","author":"Zhang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517312001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T09:27:49Z","timestamp":1543224469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517312001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0378517312001354"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2012.02.002","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}